251 related articles for article (PubMed ID: 24499991)
41. Increased risk of venous thromboembolism within the first year after Staphylococcus aureus bacteraemia: a nationwide observational matched cohort study.
Mejer N; Westh H; Schønheyder HC; Jensen AG; Larsen AR; Skov R; Benfield T;
J Intern Med; 2014 Apr; 275(4):387-97. PubMed ID: 24118528
[TBL] [Abstract][Full Text] [Related]
42. Hormonal contraception and thrombosis.
Sitruk-Ware R
Fertil Steril; 2016 Nov; 106(6):1289-1294. PubMed ID: 27678035
[TBL] [Abstract][Full Text] [Related]
43. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
Dinger J; Bardenheuer K; Heinemann K
Contraception; 2014 Apr; 89(4):253-63. PubMed ID: 24576793
[TBL] [Abstract][Full Text] [Related]
44. Clinical profile and recurrence rate in women with venous thromboembolism during combined hormonal contraceptive use: a prospective cohort study.
van Vlijmen EF; Mäkelburg AB; Knol HM; Tichelaar VI; Kluin-Nelemans HC; Veeger NJ; Meijer K
Br J Haematol; 2016 Feb; 172(4):636-8. PubMed ID: 26105591
[No Abstract] [Full Text] [Related]
45. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.
Sidney S; Cheetham TC; Connell FA; Ouellet-Hellstrom R; Graham DJ; Davis D; Sorel M; Quesenberry CP; Cooper WO
Contraception; 2013 Jan; 87(1):93-100. PubMed ID: 23083525
[TBL] [Abstract][Full Text] [Related]
46. Epidemiology of the contraceptive pill and venous thromboembolism.
Hannaford PC
Thromb Res; 2011 Feb; 127 Suppl 3():S30-4. PubMed ID: 21262435
[TBL] [Abstract][Full Text] [Related]
47. [Venous thromboembolism in adolescents associated with fourth-generation oral contraceptives].
Botzenhardt S; Toni I; Rascher W; Neubert A
Klin Padiatr; 2013 Sep; 225(5):268-76. PubMed ID: 23979828
[TBL] [Abstract][Full Text] [Related]
48. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
Johannesdottir SA; Horváth-Puhó E; Dekkers OM; Cannegieter SC; Jørgensen JO; Ehrenstein V; Vandenbroucke JP; Pedersen L; Sørensen HT
JAMA Intern Med; 2013 May; 173(9):743-52. PubMed ID: 23546607
[TBL] [Abstract][Full Text] [Related]
49. Hormonal contraception in thrombophilic adolescents: risk of thrombosis and recommendations.
Rott H
Hamostaseologie; 2012; 32(1):15-21. PubMed ID: 22009044
[TBL] [Abstract][Full Text] [Related]
50. [Pregnancy, contraception and HRT and venous thromboembolism].
Conard J; Gompel A
Rev Prat; 2007 Apr; 57(7):759-66. PubMed ID: 17626321
[TBL] [Abstract][Full Text] [Related]
51. [Diffuse symptoms in young women may indicate venous thromboembolism. Important to ask about the use of combined hormonal contraception].
Milsom I; von Sydow H; Thörn AB; Björkelund C; Odlind V
Lakartidningen; 2012 Sep 19-26; 109(38):1680-2. PubMed ID: 23094400
[No Abstract] [Full Text] [Related]
52. Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study.
Meaidi A; Mascolo A; Sessa M; Toft-Petersen AP; Skals R; Gerds TA; Wessel Skovlund C; Morch LS; Rossi F; Capuano A; Lidegaard O; Torp-Pedersen C
BMJ; 2023 Sep; 382():e074450. PubMed ID: 37673431
[TBL] [Abstract][Full Text] [Related]
53. Increased one-year risk of symptomatic venous thromboembolism following total hip replacement: a nationwide cohort study.
Pedersen AB; Johnsen SP; Sørensen HT
J Bone Joint Surg Br; 2012 Dec; 94(12):1598-603. PubMed ID: 23188898
[TBL] [Abstract][Full Text] [Related]
54. Venous thromboembolism associated with pregnancy and hormonal therapy.
Jacobsen AF; Sandset PM
Best Pract Res Clin Haematol; 2012 Sep; 25(3):319-32. PubMed ID: 22959548
[TBL] [Abstract][Full Text] [Related]
55. Non-steroidal anti-inflammatory drugs and venous thromboembolism in women.
Bergendal A; Adami J; Bahmanyar S; Hedenmalm K; Lärfars G; Persson I; Sundström A; Kieler H
Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):658-66. PubMed ID: 23508885
[TBL] [Abstract][Full Text] [Related]
56. Venous thromboembolism during pregnancy, postpartum or during contraceptive use.
Blanco-Molina A; Rota LL; Di Micco P; Brenner B; Trujillo-Santos J; Ruiz-Gamietea A; Monreal M;
Thromb Haemost; 2010 Feb; 103(2):306-11. PubMed ID: 20126835
[TBL] [Abstract][Full Text] [Related]
57. A Review of Hormonal Contraception and Venous Thromboembolism in Adolescents.
Woods GM; Kerlin BA; O'Brien SH; Bonny AE
J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):402-408. PubMed ID: 27491960
[TBL] [Abstract][Full Text] [Related]
58. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
59. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users.
Samuelsson E; Hägg S
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):674-81. PubMed ID: 15225194
[TBL] [Abstract][Full Text] [Related]
60. A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.
Douketis JD; Ginsberg JS; Holbrook A; Crowther M; Duku EK; Burrows RF
Arch Intern Med; 1997 Jul; 157(14):1522-30. PubMed ID: 9236553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
